Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 08/26/2016 - 11:59am.

  2. A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... for leukemia treatment within the last four months. Clinical evidence of CNS or pulmonary leukostasis, disseminated intravascular ...

    Clinical Trial last updated 06/03/2016 - 3:09pm.

  3. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... of registration) Respiratory compromise (DLCO < 50%) Clinical signs of heart or coronary failure or LVEF < 40%. Myocardial ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  4. Advancing Clinical Trials through Expanded Patient Input

    ... “PACCT stands for Patient Advisory Committee on Clinical Trials, and the + sign in the abbreviation indicates health services ... at which to get qualified patient input on their proposed trial. We’ve learned from research that the FDA and various funding entities ...

    Interview last updated 07/28/2016 - 9:51am.

  5. hase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:41am.

  6. A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/28/2016 - 10:54am.

  7. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.

  8. Selinexor (KPT-330) in Older Patients With Relapsed/Refractory AML (SOPRA)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 08/26/2016 - 9:21am.

  9. Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/27/2016 - 1:15pm.

  10. Clinical Utility of Lenalidomide in the Treatment of Myelodysplastic Syndromes

    ... PubMed Abstract:  Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes ... and red blood cell growth factors. The first clinical trial using lenalidomide was MDS-001 – revealing a 56% hematological ...

    Research Review last updated 05/02/2016 - 9:12am.